HPQ

HP Inc.

$25.24

+15.25%
May 22, 2026
Bobby Quantitative Model
HP Inc. is a global technology company operating in the Computer Hardware industry, focused on personal computing and printing solutions. The company is a market leader in the PC and printing markets, distinguishing itself through a strong commercial focus, a broad global customer base, and a capital-efficient, outsourced manufacturing model. The current investor narrative revolves around navigating a challenging hardware environment, characterized by concerns over margin compression from supply chain issues and a cyclical downturn in PC demand, which has triggered a significant selloff in tech hardware stocks as seen in recent market headlines.

People also watch

Arista Networks

Arista Networks

ANET

Analysis
Dell Technologies

Dell Technologies

DELL

Analysis
Western Digital

Western Digital

WDC

Analysis
Pandora

Pandora

P

Analysis
NetApp

NetApp

NTAP

Analysis

BobbyInvestment Opinion: Should I buy HPQ Today?

Rating: Hold. The core thesis is that HPQ is a deeply valued, cash-generative company trapped in a cyclical downturn with significant margin headwinds, making it unsuitable for new capital until evidence of stabilization emerges.

Supporting evidence includes a forward P/E of 7.0x, a deep 48% discount to sales (P/S of 0.47x), and strong TTM FCF of $2.88B supporting a 4.2% dividend yield. However, these positives are counterbalanced by contracting profitability (gross margin down 170 bps YoY), bearish analyst consensus (multiple Sell/Underweight ratings), and high cyclical exposure (71% of revenue from PCs). The stock trades 20% above its 52-week low, suggesting limited near-term downside but also lacking a clear catalyst for multiple expansion.

The thesis would upgrade to Buy if gross margins stabilize above 20% for two consecutive quarters or if the forward P/E compresses below 6.0x, offering an even greater margin of safety. It would downgrade to Sell if revenue growth turns negative or if operating margins fall below 4%. Relative to its history and the challenged hardware sector, the stock is fairly valued—the deep multiples accurately reflect the elevated risks.

Sign up to view all

HPQ 12-Month Price Forecast

HPQ is a classic 'show me' story. The deep valuation (7.0x forward P/E, 0.47x P/S) and 4.2% yield are compelling, but they are justified by severe margin pressures and cyclical exposure. The base case of range-bound trading is most likely, as the company's strong cash generation battles persistent fundamental headwinds. The stance would upgrade to bullish on evidence of sustained margin improvement (gross margin >20.5% for two quarters) or a significant upward revision to the $3.83 EPS consensus. It would turn bearish if the stock breaks below the $17.56 support on worsening fundamentals.

Historical Price
Current Price $25.24
Average Target $21.5
High Target $29.55
Low Target $17.56

Wall Street consensus

Most Wall Street analysts maintain a constructive view on HP Inc.'s 12-month outlook, with a consensus price target around $32.81 and implied upside of +30.0% versus the current price.

Average Target

$32.81

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$20 - $33

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Analyst coverage for HPQ is limited, with only 5 analysts providing estimates, indicating this large-cap stock has subdued institutional interest which can lead to higher volatility and less efficient price discovery. The consensus sentiment leans bearish to neutral, as evidenced by recent institutional ratings from major firms like Goldman Sachs (Sell), Morgan Stanley (Underweight), Wells Fargo (Underweight), and Barclays (Underweight). The average revenue estimate for the coming period is $58.74 billion, with a low estimate of $56.00 billion and a high of $60.46 billion, while the average EPS estimate is $3.83. The wide target range for revenue, spanning approximately $4.5 billion, signals high uncertainty among analysts regarding the company's near-term growth trajectory amid the challenging hardware environment. The prevalence of 'Underweight' and 'Sell' ratings suggests analysts see limited catalysts for multiple expansion or earnings acceleration, with the low targets likely factoring in continued margin pressure and competitive threats, while the high targets might assume a stronger-than-expected PC refresh cycle or cost discipline.

Drowning in data?

Find the real signal!

Bulls vs Bears: HPQ Investment Factors

The evidence currently tilts bearish, as the company's fundamental challenges—severe margin compression, high cyclical exposure, and negative analyst sentiment—outweigh its deep value valuation and strong cash flow. The single most important tension in the investment debate is whether HPQ's deep value multiples (7.0x forward P/E) represent a durable bargain or a value trap justified by a secular decline in its core printing business and structurally lower PC margins. The resolution hinges on whether management can halt the margin erosion evidenced by the 170 bps year-over-year gross margin decline, which would validate the bull case; continued compression would confirm the bear thesis.

Bullish

  • Deep Value Valuation: HPQ trades at a forward P/E of 7.0x and a P/S ratio of 0.47x, representing a significant discount to the broader technology hardware sector. This deep value multiple suggests the market has priced in substantial pessimism, offering a margin of safety if the PC cycle stabilizes.
  • Strong Cash Generation: The company generated $2.88 billion in trailing twelve-month free cash flow, providing ample liquidity. This cash flow supports a sustainable dividend with a 43% payout ratio and funds ongoing share repurchases, offering shareholder returns even in a downturn.
  • Recent Positive Momentum: The stock has gained 8.22% over the past month, outperforming the S&P 500's 5.6% gain, and is up 8.05% over three months. This divergence from the severe 1-year downtrend of -27.69% suggests a potential bottoming process and technical mean reversion.
  • Revenue Growth Amid Downturn: Despite a challenging hardware environment, Q1 FY26 revenue grew 6.92% year-over-year to $14.44 billion. This demonstrates the company's ability to grow its top line even during a cyclical PC demand slump.

Bearish

  • Severe Margin Compression: Gross margin contracted to 19.64% in Q1 FY26 from 21.35% a year ago, and operating margin fell to 5.26% from 6.26%. This 170 bps gross margin decline reflects intense pricing pressure and component cost headwinds, directly threatening profitability.
  • Heavy Reliance on Cyclical PC Market: The Personal Systems segment generated $10.25B (71% of Q1 revenue), making HPQ highly exposed to the volatile PC refresh cycle. With recent news highlighting hardware margin compression and sell-offs, this concentration is a major earnings risk.
  • Overwhelmingly Bearish Analyst Sentiment: Major firms like Goldman Sachs, Morgan Stanley, Wells Fargo, and Barclays all rate HPQ as Sell or Underweight. This consensus reflects a lack of near-term catalysts and deep skepticism about the company's ability to overcome industry headwinds.
  • Weak Liquidity and Negative Equity: The current ratio of 0.77 indicates potential short-term liquidity constraints. Furthermore, a negative ROE of -7.31% and a negative debt-to-equity ratio of -31.45, stemming from aggressive buybacks, signal a strained financial structure that limits strategic flexibility.

HPQ Technical Analysis

HPQ is in a sustained downtrend, evidenced by a 1-year price change of -27.69%, with the stock trading near the bottom of its 52-week range, currently at $20.81 compared to a 52-week high of $29.55 and a low of $17.56. This positioning, approximately 20% above the 52-week low, suggests the stock is in a deep correction but not at absolute lows, potentially indicating a value opportunity if fundamentals stabilize, though it remains a 'falling knife' in a weak sector. Recent momentum shows a modest short-term recovery, with the stock up 8.22% over the past month and 8.05% over the past three months, diverging positively from the severe 1-year downtrend and hinting at a potential bottoming or mean reversion process. The stock's beta of 1.108 indicates it is roughly 11% more volatile than the broader market (SPY), which has gained 25.19% over the past year, highlighting HPQ's significant underperformance and high idiosyncratic risk. Key technical levels are clear, with immediate resistance at the 52-week high of $29.55 and strong support at the 52-week low of $17.56; a decisive break below $17.56 would signal a continuation of the bearish trend, while a sustained move above recent highs near $22-23 could indicate a more durable recovery is underway.

Beta

1.11

1.11x market volatility

Max Drawdown

-38.0%

Largest decline past year

52-Week Range

$18-$30

Price range past year

Annual Return

-11.4%

Cumulative gain past year

PeriodHPQ ReturnS&P 500
1m+23.5%+4.8%
3m+35.8%+8.2%
6m+5.3%+13.1%
1y-11.4%+27.9%
ytd+14.1%+9.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

HPQ Fundamental Analysis

HPQ's revenue trajectory shows modest growth but significant quarterly volatility; the most recent Q1 FY26 revenue was $14.44 billion, representing a 6.92% year-over-year increase, yet this follows a sequential decline from Q4 FY25's $14.64 billion, indicating potential demand softness. The Personal Systems Group, at $10.25 billion, remains the dominant revenue driver compared to Printing's $4.19 billion, highlighting the company's heavy reliance on the cyclical PC market. The company remains profitable but faces margin pressure, with Q1 FY26 net income of $545 million and a gross margin of 19.64%, which has compressed from 21.35% a year prior (Q1 FY25), reflecting the challenging pricing and component cost environment noted in recent news. Operating income of $759 million in Q1 FY26 translates to an operating margin of 5.26%, down from 6.26% in the year-ago quarter, signaling profitability headwinds. The balance sheet and cash flow position is mixed, with a negative ROE of -7.31% and a negative debt-to-equity ratio of -31.45, which is an accounting artifact likely due to negative shareholder equity from large share buybacks. However, the company generates substantial cash, with trailing twelve-month free cash flow of $2.88 billion, providing ample liquidity to fund its dividend (payout ratio of 43%) and share repurchases, though the current ratio of 0.77 suggests some short-term liquidity constraints relative to industry norms.

Quarterly Revenue

$14.4B

2026-01

Revenue YoY Growth

+0.06%

YoY Comparison

Gross Margin

+0.19%

Latest Quarter

Free Cash Flow

$2.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Personal Systems Group
Printing

Open an Account, get $2 TSLA now!

Valuation Analysis: Is HPQ Overvalued?

Given HPQ's positive net income of $545 million in the last quarter, the primary valuation metric is the P/E ratio. The trailing P/E is 10.35x, while the forward P/E is significantly lower at 7.00x, indicating the market expects earnings growth or a recovery from recent depressed levels. Compared to sector averages, HPQ's trailing P/E of 10.35x trades at a discount to the broader technology hardware sector, which often carries higher multiples, suggesting the market is pricing in the company's mature, cyclical profile and margin pressures. The stock's price-to-sales ratio of 0.47x and EV/Sales of 0.48x further underscore a deep value multiple relative to sales. Historically, the stock's own valuation has compressed significantly; for instance, its trailing P/E has ranged from highs above 15x in early 2025 to current levels near 10x. Trading near the lower end of its historical P/E band suggests the stock is pricing in significant pessimism, which could represent a value opportunity if the PC cycle stabilizes, but also reflects justified concerns over secular decline in its core printing business and cyclical PC headwinds.

PE

10.4x

Latest Quarter

vs. Historical

High-End

5-Year PE Range -3383x~15x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

8.2x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks are pronounced. HPQ faces significant margin pressure, with gross margin compressing 170 basis points year-over-year to 19.64% in Q1 FY26. The company's heavy reliance on the cyclical PC market, where its Personal Systems Group constitutes 71% of revenue, creates high earnings volatility. Furthermore, a current ratio of 0.77 signals potential short-term liquidity constraints, and the negative shareholder equity (ROE of -7.31%) resulting from large buybacks limits financial flexibility for acquisitions or debt-funded investments.

Market & Competitive Risks are elevated. HPQ trades at a deep discount (forward P/E of 7.0x) because the market anticipates further deterioration, creating valuation compression risk if the PC downturn deepens. The stock's beta of 1.108 indicates it is 11% more volatile than the market, which has gained 25.19% over the past year while HPQ fell 27.69%, highlighting high idiosyncratic risk. Recent news highlights a sector-wide tech selloff triggered by 'hardware margin compression from memory shortages,' a direct threat to HPQ's core business model.

Worst-Case Scenario involves a prolonged PC demand slump combined with an inability to manage component costs, leading to consecutive quarters of margin misses and earnings declines. This could trigger a wave of analyst downgrades from an already bearish consensus, pushing the stock to retest and break its 52-week low of $17.56. A realistic downside from the current price of $20.81 is approximately -16% to that technical support level. In an extended bear market for hardware, the stock could approach levels implied by a forward P/E of 5-6x, implying a further 20-30% decline from current prices.

FAQ

The key risks are, in order of severity: 1) Margin Erosion: Gross margin fell to 19.64% in Q1 FY26, and further compression could crush earnings. 2) Cyclical Demand: 71% of revenue comes from the volatile PC market, which is in a downturn. 3) Financial Structure: Negative shareholder equity and a low current ratio of 0.77 limit financial flexibility. 4) Sentiment & Liquidity: With only 5 analyst covers and predominantly Sell ratings, the stock faces headwinds in attracting institutional capital, which can exacerbate volatility.

The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $20 and $23, as sluggish PC demand and margin pressure persist but are offset by the dividend. The Bull Case (25% probability) targets $27-$29.55 on a PC market recovery and margin stabilization. The Bear Case (15% probability) risks a fall to $17.56-$19 if the downturn deepens. The base case is most likely, anchored by the analyst EPS consensus of $3.83 and the current forward P/E of 7.0x.

HPQ is fairly valued relative to its risks. While its forward P/E of 7.0x and P/S of 0.47x appear deeply undervalued compared to the technology sector, these multiples are appropriate given the company's challenged fundamentals: margin compression, cyclical exposure, and negative analyst ratings. The valuation implies the market expects low-to-no growth and continued profitability pressure. Therefore, it is not a clear bargain but a fair price for a company in a difficult phase of its cycle.

HPQ is a situational buy, not a core holding. For deep-value investors seeking high yield (4.2%) and willing to accept high cyclical risk, the current forward P/E of 7.0x offers a margin of safety. However, given the severe margin compression (gross margin down 170 bps YoY) and overwhelmingly bearish analyst sentiment, it is not a good buy for growth-oriented or risk-averse investors. It could be a good buy for income-focused portfolios if purchased in stages, acknowledging the realistic 16% downside risk to the 52-week low of $17.56.

HPQ is primarily suitable for a long-term (3+ year) investment horizon for investors betting on a full PC cycle recovery. Its high beta (1.108) and exposure to cyclical news flow make it a poor short-term trading vehicle. The 4.2% dividend yield and buyback program are designed for patient capital. Given the lack of near-term growth catalysts and the need for the industry cycle to play out, a minimum holding period of 18-24 months is suggested to potentially realize the value opportunity.